APA (7th ed.) Citation

JR, C., JT, V., WJ, A., A, S., WG, M., J, L., . . . DG, O. (2013). Clinical proof-of-concept study with MSDC-0160, a prototype mTOT-modulating insulin sensitizer. Clinical pharmacology and therapeutics, 93(4), 352. https://doi.org/10.1038/clpt.2013.10

Chicago Style (17th ed.) Citation

JR, Colca, VanderLugt JT, Adams WJ, Shashlo A, McDonald WG, Liang J, Zhou R, and Orloff DG. "Clinical Proof-of-concept Study with MSDC-0160, a Prototype MTOT-modulating Insulin Sensitizer." Clinical Pharmacology and Therapeutics 93, no. 4 (2013): 352. https://doi.org/10.1038/clpt.2013.10.

MLA (9th ed.) Citation

JR, Colca, et al. "Clinical Proof-of-concept Study with MSDC-0160, a Prototype MTOT-modulating Insulin Sensitizer." Clinical Pharmacology and Therapeutics, vol. 93, no. 4, 2013, p. 352, https://doi.org/10.1038/clpt.2013.10.